Table: Jcr Pharmaceuticals - 6-MTH group results

JCR Pharmaceuticals

26/10/2022 07:30

Oct 26 (Reuters)- 
             Jcr Pharmaceuticals Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Sep 30, 2022        Sep 30, 2021     Mar 31, 2023 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               15.58               28.38            45.00    
                   (-45.1 pct)        (+159.2 pct)      (-11.9 pct) 
  Operating          744 mln              13.64            14.50    
                   (-94.5 pct)        (+943.3 pct)      (-27.3 pct) 
  Recurring            1.57               13.73            14.50    
                   (-88.6 pct)        (+916.4 pct)      (-29.3 pct) 
  Net                962 mln               9.23            10.30    
                   (-89.6 pct)        (+652.6 pct)      (-29.0 pct) 
  EPS               7.77 yen            74.66 yen        83.25 yen  
  EPS Diluted       7.74 yen            74.36 yen                   
  Ann Div                               22.00 yen        20.00 yen  
  -Q2 div           10.00 yen           10.00 yen                   
  -Q4 div                               12.00 yen        10.00 yen  
  
  NOTE - Jcr Pharmaceuticals Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4552.T